Chemical disease-free survival in localized carcinoma of prostate treated with external beam irradiation: comparison of American Society of Therapeutic Radiology and Oncology Consensus or 1 ng/mL as endpoint (Q73711026)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 April 2001

Language	Label	Description	Also known as
English	Chemical disease-free survival in localized carcinoma of prostate treated with external beam irradiation: comparison of American Society of Therapeutic Radiology and Oncology Consensus or 1 ng/mL as endpoint	scientific article published on 01 April 2001

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11286836%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Chemical disease-free survival in localized carcinoma of prostate treated with external beam irradiation: comparison of American Society of Therapeutic Radiology and Oncology Consensus or 1 ng/mL as endpoint (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11286836%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

C A Perez

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11286836%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J M Michalski

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11286836%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M A Lockett

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11286836%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

0 references

publication date

1 April 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11286836%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11286836%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

49

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11286836%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11286836%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1287-1296

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11286836%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Localized carcinoma of the prostate (Stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The fall and rise of prostate-specific antigen: Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostatic-specific antigen doubling times in patients with prostate cancer: a potentially useful reflection of tumor doubling time

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pretreatment prostate-specific antigen doubling times: clinical utility of this predictor of prostate cancer behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate Specific Antigen in the Management of Patients with Localized Adenocarcinoma of the Prostate Treated with Primary Radiation Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen and external beam radiation therapy in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate Specific Antigen after External Beam Radiotherapy for Prostatic Cancer: Followup

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate Specific Antigen after Irradiation for Prostatic Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen nadir of 0.5 ng/mL or less defines disease freedom for surgically staged men irradiated for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Brachytherapy for clinically localized prostate cancer: results at 7- and 8-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

An analysis of clinical and treatment related prognostic factors on outcome using biochemical control as an end-point in patients with prostate cancer treated with external beam irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Maximum utilization of the life table method in analyzing survival

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy options for localized prostate cancer based upon pretreatment serum prostate-specific antigen levels and biochemical control: a comprehensive review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of pretherapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective study of prostate specific antigen levels in patients receiving radiotherapy for localized carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Localized prostate cancer: use of serial prostate-specific antigen measurements during radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum prostate-specific antigen in monitoring the response of carcinoma of the prostate to radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostatic specific antigen as an indicator of response to radiotherapy in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen density: a new prognostic indicator for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate Specific Antigen as an Outcome Variable for T1 and T2 Prostate Cancer Treated by Radiation Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Current Status of Prostate-Specific Antigen in the Radiotherapeutic Management of Prostatic Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of pelvic radiation therapy on serum levels of prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The long-term effect on PSA values of incidental prostatic irradiation in patients with pelvic malignancies other than prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Value of Serial Prostate Specific Antigen Determinations 5 Years after Radiotherapy: Steeply Increasing Values Characterize 80% of Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comments on the treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome--regarding Zietman et al., IJROBP 32:287-292; 1995

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen and radiation therapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum prostate-specific antigen profile following radiotherapy for prostate cancer: implications for patterns of failure and definition of cure

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A model of prostatic carcinoma tumor kinetics based on prostate specific antigen levels after radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A method for determining a prostate-specific antigen cure after radiation therapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in biochemical disease-free survival rates as a result of adoption of the consensus conference definition in patients with clinically localized prostate cancer treated with external-beam radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901492-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(00)01492-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11286836%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11286836%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73711026&oldid=1671958544"